Gout Management Guidelines

Introduction to Gout Management

• Gout management involves a treat-to-target strategy with serum uric acid (SUA) measurements to achieve target levels, as recommended by the American College of Rheumatology and the European League Against Rheumatism 1, 2, 3

Treatment Targets and Monitoring

• The standard target for SUA is <6 mg/dL for all patients on urate-lowering therapy (ULT), with a lower target of <5 mg/dL recommended for patients with severe gout, chronic arthropathy, or frequent attacks 1, 2
• SUA should be maintained <6 mg/dL lifelong to prevent crystal reformation, with regular monitoring to ensure levels remain at target 2
• If a patient continues to experience flares despite target SUA, consideration should be given to extending prophylaxis, lowering the SUA target, or evaluating for other causes of inflammation 2

Urate-Lowering Therapy Initiation and Titration

• The American College of Rheumatology recommends starting with low-dose allopurinol (100 mg daily) and increasing the dose every 2-4 weeks until target SUA is achieved, with SUA checks after each dose increase 1, 2, 3
• Anti-inflammatory prophylaxis should always be provided when starting ULT, and continued for 3-6 months, with options including colchicine (0.5-1 mg/day) or low-dose NSAIDs 1, 2, 3
• Febuxostat is an alternative option for urate-lowering therapy, and uricosuric agents such as probenecid can be used in combination with allopurinol for enhanced urate lowering, but are contraindicated in patients with a history of urolithiasis 2, 3

Medications for Gout Management

• The following table summarizes the recommended medications for gout management:

2, 3

Lifestyle Modifications and Prevention

• Patients should reduce their intake of purines (meat, seafood), limit alcohol (especially beer), avoid sugar-sweetened drinks, and encourage low-fat dairy products, with a goal of achieving and maintaining a healthy weight and reducing the risk of gout attacks 2, 3
• Weight loss if obese, reduced alcohol consumption, and addressing associated conditions such as hypertension, hyperlipidemia, and hyperglycemia are recommended lifestyle modifications 2, 3
• Consider discontinuing diuretics if possible, and alternative medications with uricosuric effects such as losartan for hypertension and fenofibrate for hyperlipidemia can be used 3

Special Considerations

• In patients with renal impairment, the allopurinol dose should be adjusted based on creatinine clearance, with consideration of alternative medications such as febuxostat or benzbromarone, and concomitant medications should be carefully considered 2, 4
• Diagnostic errors can be avoided by confirming diagnosis with synovial fluid analysis for monosodium urate crystals, and inadequate dosing, premature discontinuation, overlooking prophylaxis, and inadequate monitoring are common treatment errors that can be avoided by following the recommended treatment approach 5, 2, 3
• Intra-articular corticosteroid injection is effective and safe for monoarticular attacks, particularly when NSAIDs/colchicine are contraindicated, and requires joint aspiration which also aids diagnosis 3